De Salvo G, Thulasidharan S, Barbara R, Penwarden A, Aggarwal N, Frisina R
Eye (Lond). 2024; 38(16):3072-3076.
PMID: 38992142
PMC: 11544236.
DOI: 10.1038/s41433-024-03221-y.
Kunstek H, Vreken F, Keita A, Hamblin M, Dumarcay F, Varbanov M
Pharmaceuticals (Basel). 2022; 15(7).
PMID: 35890156
PMC: 9316526.
DOI: 10.3390/ph15070858.
Singh R, Yang X
AIP Adv. 2022; 12(4):045020.
PMID: 35465057
PMC: 9020880.
DOI: 10.1063/5.0082429.
Mazzeo T, Leber H, Silva A, Freire R, Barbosa G, Criado G
Graefes Arch Clin Exp Ophthalmol. 2021; 260(3):723-735.
PMID: 34648069
DOI: 10.1007/s00417-021-05450-3.
Pichai J, Vanchalerm B, Mansing R
BMC Ophthalmol. 2021; 21(1):30.
PMID: 33430812
PMC: 7802284.
DOI: 10.1186/s12886-020-01796-0.
Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy.
Yang J, Yuan M, Xia S, Chen Y
J Ophthalmol. 2020; 2019:1609717.
PMID: 31949949
PMC: 6948291.
DOI: 10.1155/2019/1609717.
The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.
Teo K, Gillies M, Fraser-Bell S
Int J Mol Sci. 2018; 19(9).
PMID: 30177632
PMC: 6165414.
DOI: 10.3390/ijms19092611.
Removal of choroidal vasculature using concurrently applied ultrasound bursts and nanosecond laser pulses.
Zhang H, Xie X, Li J, Qin Y, Zhang W, Cheng Q
Sci Rep. 2018; 8(1):12848.
PMID: 30150731
PMC: 6110758.
DOI: 10.1038/s41598-018-31045-w.
High-precision, non-invasive anti-microvascular approach via concurrent ultrasound and laser irradiation.
Hu Z, Zhang H, Mordovanakis A, Paulus Y, Liu Q, Wang X
Sci Rep. 2017; 7:40243.
PMID: 28074839
PMC: 5225605.
DOI: 10.1038/srep40243.
Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Liu C, Chen L, Tsai S, Lai C, Chan W, Wu W
J Ocul Pharmacol Ther. 2014; 30(5):400-5.
PMID: 24597844
PMC: 4043472.
DOI: 10.1089/jop.2013.0169.
Genetic predictors of response to photodynamictherapy.
Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, Perri P, DAngelo S
Mol Diagn Ther. 2011; 15(4):195-210.
PMID: 21913742
DOI: 10.1007/BF03256411.
Reactive macular edema and acute visual loss after photodynamic therapy on the same day of fluorescein angiography.
Lin C, Hwang J, Chen S
Oman J Ophthalmol. 2011; 4(2):84-6.
PMID: 21897625
PMC: 3160076.
DOI: 10.4103/0974-620X.83660.
A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agents.
Butler M, Itotia P, Sullivan J
Invest Ophthalmol Vis Sci. 2009; 51(5):2705-20.
PMID: 19834043
PMC: 2868480.
DOI: 10.1167/iovs.08-2862.
Capillary dropout after photodynamic therapy in a patient with Bechet's disease.
Chien K, Chang Y, Chen C, Chen J
Graefes Arch Clin Exp Ophthalmol. 2009; 247(12):1715-7.
PMID: 19672615
DOI: 10.1007/s00417-009-1157-8.
Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography.
Koizumi H, Iida T, Saito M, Nagayama D, Maruko I
Graefes Arch Clin Exp Ophthalmol. 2007; 246(4):515-20.
PMID: 17972093
DOI: 10.1007/s00417-007-0705-3.
Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation.
Rouvas A, Papakostas T, Ladas I, Vergados I
Graefes Arch Clin Exp Ophthalmol. 2007; 246(2):315-8.
PMID: 17957379
DOI: 10.1007/s00417-007-0669-3.
Chorioretinal anastomosis after photodynamic therapy for polypoidal choroidal vasculopathy: CRA after PDT for PCV.
Yodoi Y, Tsujikawa A, Otani A, Aikawa H, Yoshimura N
Int Ophthalmol. 2007; 28(4):297-9.
PMID: 17701101
DOI: 10.1007/s10792-007-9129-7.
Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.
Kang S, Schmack I, Benson H, Grossniklaus H
Br J Ophthalmol. 2007; 91(12):1602-6.
PMID: 17567659
PMC: 2095496.
DOI: 10.1136/bjo.2007.121830.
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
Chan W, Lai T, Wong A, Liu D, Lam D
Br J Ophthalmol. 2006; 91(2):174-9.
PMID: 16987898
PMC: 1857631.
DOI: 10.1136/bjo.2006.103606.
Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia.
Ohno-Matsui K, Moriyama M, Hayashi K, Mochizuki M
Graefes Arch Clin Exp Ophthalmol. 2006; 244(10):1363-6.
PMID: 16523294
DOI: 10.1007/s00417-006-0303-9.
